Annexon Biosciences's total assets for Q4 2024 were $350.07M, a decrease of -7.58% from the previous quarter. ANNX total liabilities were $56.97M for the fiscal quarter, a 20.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.